GLPharmTech Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Stock Symbol
  • 204840
Stock Symbol

GLPharmTech General Information

Description

Operator of a drug development company intended to develop medicinal drugs. The company specializes in the formulation and development of an improved version of currently marketed generic pharmaceuticals through delivery technologies to cure various diseases such as eye care, diabetes among others, enabling the healthcare industry to improve treatment for various health issues.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
KRX
Primary Office
  • Number 714, Jungang Industry, 137 Sagimakgol-ro
  • Jungwon-gu
  • Seongnam-si, Gyeonggi-do
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GLPharmTech Financials Summary

In Thousands,
USD
TTM 31-Dec-2015 FY 2015 31-Dec-2015
Revenue 5,750 5,750
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GLPharmTech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GLPharmTech‘s full profile, request access.

Request a free trial

GLPharmTech Executive Team (2)

Name Title Board Seat Contact Info
Brian Wang Chief Executive Officer
Park Jun Sang Director, Research & Development
To view GLPharmTech’s complete executive team members history, request access »

GLPharmTech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GLPharmTech‘s full profile, request access.

Request a free trial